When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn…
Source:Bayer, MD Anderson partner to evaluate how a drug may affect patient’s disease-related symptoms
Sunday, January 25, 2015
Bayer, MD Anderson partner to evaluate how a drug may affect patient’s disease-related symptoms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment